These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. New paradigms in anticancer therapy: targeting multiple signaling pathways with kinase inhibitors. Faivre S; Djelloul S; Raymond E Semin Oncol; 2006 Aug; 33(4):407-20. PubMed ID: 16890796 [TBL] [Abstract][Full Text] [Related]
3. Understanding resistance to targeted cancer drugs through loss of function genetic screens. Berns K; Bernards R Drug Resist Updat; 2012 Oct; 15(5-6):268-75. PubMed ID: 23142522 [TBL] [Abstract][Full Text] [Related]
4. Modulation of cell sensitivity to antitumor agents by targeting survival pathways. Perego P; Cossa G; Zuco V; Zunino F Biochem Pharmacol; 2010 Nov; 80(10):1459-65. PubMed ID: 20688050 [TBL] [Abstract][Full Text] [Related]
6. Targeting PI3K signaling as a therapeutic approach for colorectal cancer. Zhang J; Roberts TM; Shivdasani RA Gastroenterology; 2011 Jul; 141(1):50-61. PubMed ID: 21723986 [TBL] [Abstract][Full Text] [Related]
7. Autophagy signaling in cancer and its potential as novel target to improve anticancer therapy. Moretti L; Yang ES; Kim KW; Lu B Drug Resist Updat; 2007; 10(4-5):135-43. PubMed ID: 17627865 [TBL] [Abstract][Full Text] [Related]
8. The biological framework: translational research from bench to clinic. Yarden Y Oncologist; 2010; 15 Suppl 5():1-7. PubMed ID: 21138950 [TBL] [Abstract][Full Text] [Related]
9. [Drug resistance mediated by survival- and growth-promoting signaling pathways]. Fujita N Gan To Kagaku Ryoho; 2009 Apr; 36(4):567-71. PubMed ID: 19381028 [TBL] [Abstract][Full Text] [Related]
10. Novel targeted agents for the treatment of advanced breast cancer. de la Vega M; Díaz-Cantón E; Alvarez RH Future Med Chem; 2012 May; 4(7):893-914. PubMed ID: 22571614 [TBL] [Abstract][Full Text] [Related]
11. Nanomedicine for targeted cancer therapy: towards the overcoming of drug resistance. Shapira A; Livney YD; Broxterman HJ; Assaraf YG Drug Resist Updat; 2011 Jun; 14(3):150-63. PubMed ID: 21330184 [TBL] [Abstract][Full Text] [Related]
12. The biological framework: translational research from bench to clinic. Yarden Y Oncologist; 2011; 16 Suppl 1():23-9. PubMed ID: 21278438 [TBL] [Abstract][Full Text] [Related]
13. Wnt signaling and cancer development: therapeutic implication. Paul S; Dey A Neoplasma; 2008; 55(3):165-76. PubMed ID: 18348648 [TBL] [Abstract][Full Text] [Related]
14. Kinases as targets in the treatment of solid tumors. Giamas G; Man YL; Hirner H; Bischof J; Kramer K; Khan K; Ahmed SS; Stebbing J; Knippschild U Cell Signal; 2010 Jul; 22(7):984-1002. PubMed ID: 20096351 [TBL] [Abstract][Full Text] [Related]
15. Progress in cancer therapy targeting c-Met signaling pathway. Jung KH; Park BH; Hong SS Arch Pharm Res; 2012 Mar; 35(4):595-604. PubMed ID: 22553051 [TBL] [Abstract][Full Text] [Related]
16. New targets and targeted drugs for the treatment of cancer: an outlook to pediatric oncology. Rossig C; Juergens H; Berdel WE Pediatr Hematol Oncol; 2011 Oct; 28(7):539-55. PubMed ID: 21936619 [TBL] [Abstract][Full Text] [Related]
17. Translation regulation as a therapeutic target in cancer. Grzmil M; Hemmings BA Cancer Res; 2012 Aug; 72(16):3891-900. PubMed ID: 22850420 [TBL] [Abstract][Full Text] [Related]